HEALTH● LOWAug 6 · Aug 6, 2026, 10:45 PM
Immunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per year
Seeking Alpha Tech
Immunocore plans to release data for TEBE-AM by late 2026 and expand its KIMMTRAK treatment to over 1,000 patients annually. This highlights the company's progress in clinical development and patient reach for its therapies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoThis napping habit may be a heart disease warning sign , doctors say – NBC4 Washingtonnbcwashington.com · United StatesHEALTH1h agoThis napping habit may be a heart disease warning sign , doctors say – NBC Connecticutnbcconnecticut.com · United StatesHEALTH1h agoFull list of Nottinghamshire doctors banned from medical profession in 2026nottinghampost.com · United KingdomHEALTH2h agoPopularity was never my goal; what matters is public health: Tukaram MundheThe Hindu